Bank of America’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$410M Buy
1,257,328
+192,755
+18% +$62.9M 0.03% 455
2025
Q1
$287M Buy
1,064,573
+646,021
+154% +$174M 0.02% 538
2024
Q4
$98.5M Sell
418,552
-132,220
-24% -$31.1M 0.01% 918
2024
Q3
$151M Sell
550,772
-80,340
-13% -$22.1M 0.01% 790
2024
Q2
$153M Buy
631,112
+146,219
+30% +$35.5M 0.01% 740
2024
Q1
$72.5M Buy
484,893
+168,660
+53% +$25.2M 0.01% 1096
2023
Q4
$60.5M Sell
316,233
-34,920
-10% -$6.68M 0.01% 1056
2023
Q3
$62.2M Sell
351,153
-1,190
-0.3% -$211K 0.01% 1025
2023
Q2
$66.9M Sell
352,343
-418,862
-54% -$79.6M 0.01% 987
2023
Q1
$154M Buy
771,205
+467,996
+154% +$93.7M 0.02% 672
2022
Q4
$72.1M Buy
303,209
+65,400
+28% +$15.5M 0.01% 950
2022
Q3
$47.6M Sell
237,809
-4,288
-2% -$858K 0.01% 1145
2022
Q2
$35.3M Sell
242,097
-35,160
-13% -$5.13M ﹤0.01% 1326
2022
Q1
$45.3M Buy
277,257
+12,779
+5% +$2.09M ﹤0.01% 1291
2021
Q4
$44.8M Sell
264,478
-39,706
-13% -$6.73M ﹤0.01% 1301
2021
Q3
$57.4M Buy
304,184
+1,403
+0.5% +$265K 0.01% 1139
2021
Q2
$51.3M Buy
302,781
+18,090
+6% +$3.07M 0.01% 1222
2021
Q1
$40.2M Buy
284,691
+16,064
+6% +$2.27M ﹤0.01% 1319
2020
Q4
$34.9M Sell
268,627
-43,364
-14% -$5.64M ﹤0.01% 1262
2020
Q3
$45.4M Sell
311,991
-11,040
-3% -$1.61M 0.01% 1043
2020
Q2
$47.8M Sell
323,031
-133,312
-29% -$19.7M 0.01% 974
2020
Q1
$49.7M Buy
456,343
+233,925
+105% +$25.5M 0.01% 885
2019
Q4
$25.6M Sell
222,418
-59,291
-21% -$6.83M ﹤0.01% 1455
2019
Q3
$22.7M Buy
281,709
+18,909
+7% +$1.52M ﹤0.01% 1502
2019
Q2
$19.1M Buy
262,800
+634
+0.2% +$46K ﹤0.01% 1651
2019
Q1
$24.5M Buy
262,166
+164,065
+167% +$15.3M ﹤0.01% 1447
2018
Q4
$7.15M Sell
98,101
-30,067
-23% -$2.19M ﹤0.01% 2265
2018
Q3
$11.2M Sell
128,168
-133
-0.1% -$11.6K ﹤0.01% 2069
2018
Q2
$12.6M Sell
128,301
-20,737
-14% -$2.04M ﹤0.01% 1932
2018
Q1
$17.8M Buy
149,038
+25,686
+21% +$3.06M ﹤0.01% 1642
2017
Q4
$15.7M Buy
123,352
+48,455
+65% +$6.16M ﹤0.01% 1731
2017
Q3
$8.8M Buy
74,897
+26,859
+56% +$3.16M ﹤0.01% 2273
2017
Q2
$3.83M Buy
48,038
+8,369
+21% +$668K ﹤0.01% 2821
2017
Q1
$2.03M Sell
39,669
-7,295
-16% -$374K ﹤0.01% 3289
2016
Q4
$1.76M Buy
46,964
+21,079
+81% +$789K ﹤0.01% 3298
2016
Q3
$1.75M Sell
25,885
-15,687
-38% -$1.06M ﹤0.01% 3190
2016
Q2
$2.31M Buy
41,572
+12,800
+44% +$710K ﹤0.01% 2949
2016
Q1
$1.81M Sell
28,772
-45,592
-61% -$2.86M ﹤0.01% 3051
2015
Q4
$7M Buy
74,364
+45,251
+155% +$4.26M ﹤0.01% 2123
2015
Q3
$2.34M Sell
29,113
-13,339
-31% -$1.07M ﹤0.01% 2933
2015
Q2
$5.09M Buy
42,452
+16,659
+65% +$2M ﹤0.01% 2019
2015
Q1
$2.69M Buy
25,793
+14,875
+136% +$1.55M ﹤0.01% 2357
2014
Q4
$1.06M Sell
10,918
-7,036
-39% -$682K ﹤0.01% 3081
2014
Q3
$1.4M Sell
17,954
-57,667
-76% -$4.51M ﹤0.01% 2833
2014
Q2
$4.78M Buy
75,621
+67,821
+870% +$4.28M ﹤0.01% 2015
2014
Q1
$524K Sell
7,800
-4,711
-38% -$316K ﹤0.01% 3495
2013
Q4
$804K Buy
12,511
+2,090
+20% +$134K ﹤0.01% 3303
2013
Q3
$667K Sell
10,421
-65,343
-86% -$4.18M ﹤0.01% 3296
2013
Q2
$2.35M Buy
+75,764
New +$2.35M ﹤0.01% 2332